Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 4 1Phase 3 1

Status

Recruiting 2Not yet recruiting 2Completed 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Dermatologic 1CNS 1Breast 1

Conditions

Prostatic Neoplasms 1Meningeal Neoplasms 1Melanoma 1Lung Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

pembrolizumab 1273Specimen Handling 871Carboplatin 832Magnetic Resonance Spectroscopy 808Cyclophosphamide 803Cisplatin 729Nivolumab 659Paclitaxel 631Radiotherapy 574Gemcitabine 572Biopsy 529Bevacizumab 476Dexamethasone 440fludarabine 407Docetaxel 378venetoclax 370Oxaliplatin 365Capecitabine 358Fluorouracil 355atezolizumab 344durvalumab 334Rituximab 333Doxorubicin 317Radiosurgery 309Pemetrexed 306Drug Therapy 303Ipilimumab 294Standard of Care 293Etoposide 285Radiation 281

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × gadopiclenol × 1 year × Clear all
NCT06086704 2026-05-18

Study of 18F-FFNP Breast PET/MRI

University of Wisconsin, Madison

Phase 2 Recruiting
53 enrolled
Breast

Breast Neoplasms

NCT07415018 2026-04-14

Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal Disease

M.D. Anderson Cancer Center

Phase NA Not yet recruiting
40 enrolled

Meningeal Neoplasms

NCT07492121 2026-03-25

GAPIMET

University of Zurich

Phase 2 Not yet recruiting
180 enrolled
DermatologicThoracic

Lung Neoplasms, Melanoma

NCT06057168 2026-01-29

GDX-44-016

Guerbet

Phase 3 Completed
138 enrolled 7 charts
CNS

Brain Neoplasms

NCT06226129 2025-10-20

Gadopiclenol in Contrast Enhanced MRI of the Prostate

Columbia University

Phase 4 Recruiting
150 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡